These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

52 related items for PubMed ID: 12664344

  • 1. Increased serum bone sialoprotein concentrations in patients with Crohn's disease.
    Faust D, Menge F, Armbruster FP, Lembcke B, Stein J.
    Z Gastroenterol; 2003 Mar; 41(3):243-7. PubMed ID: 12664344
    [Abstract] [Full Text] [Related]

  • 2. Femoral neck osteopenia in patients with inflammatory bowel disease.
    Pollak RD, Karmeli F, Eliakim R, Ackerman Z, Tabb K, Rachmilewitz D.
    Am J Gastroenterol; 1998 Sep; 93(9):1483-90. PubMed ID: 9732930
    [Abstract] [Full Text] [Related]

  • 3. C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study.
    Henriksen M, Jahnsen J, Lygren I, Stray N, Sauar J, Vatn MH, Moum B, IBSEN Study Group.
    Gut; 2008 Nov; 57(11):1518-23. PubMed ID: 18566104
    [Abstract] [Full Text] [Related]

  • 4. Increased urinary N-telopeptide cross-linked type 1 collagen predicts bone loss in patients with inflammatory bowel disease.
    Dresner-Pollak R, Karmeli F, Eliakim R, Ackerman Z, Rachmilewitz D.
    Am J Gastroenterol; 2000 Mar; 95(3):699-704. PubMed ID: 10710060
    [Abstract] [Full Text] [Related]

  • 5. [Pathological bone density in chronic inflammatory bowel diseases--prevalence and risk factors].
    Von Tirpitz C, Pischulti G, Klaus J, Rieber A, Brückel J, Böhm BO, Adler G, Reinshagen M.
    Z Gastroenterol; 1999 Jan; 37(1):5-12. PubMed ID: 10091278
    [Abstract] [Full Text] [Related]

  • 6. [Improvement of bone metabolism after infliximab therapy in Crohn's disease].
    Miheller P, Muzes G, Zágoni T, Tóth M, Rácz K, Tulassay Z.
    Orv Hetil; 2005 Jul 10; 146(28):1477-80. PubMed ID: 16130441
    [Abstract] [Full Text] [Related]

  • 7. [The usefulness of reactive protein C in managing patients with ulcerative colitis and Crohn's disease].
    López Morante AJ, Sáez-Royuela F, Yuguero del Moral L, Martín Lorente JL, Ojeda Giménez C.
    Rev Esp Enferm Dig; 1993 Jan 10; 83(1):5-9. PubMed ID: 8452705
    [Abstract] [Full Text] [Related]

  • 8. High prevalence of morphometric vertebral deformities in patients with inflammatory bowel disease.
    Heijckmann AC, Huijberts MS, Schoon EJ, Geusens P, de Vries J, Menheere PP, van der Veer E, Wolffenbuttel BH, Stockbrugger RW, Dumitrescu B, Nieuwenhuijzen Kruseman AC.
    Eur J Gastroenterol Hepatol; 2008 Aug 10; 20(8):740-7. PubMed ID: 18617778
    [Abstract] [Full Text] [Related]

  • 9. Rapid improvement of bone metabolism after infliximab treatment in Crohn's disease.
    Franchimont N, Putzeys V, Collette J, Vermeire S, Rutgeerts P, De Vos M, Van Gossum A, Franchimont D, Fiasse R, Pelckmans P, Malaise M, Belaiche J, Louis E.
    Aliment Pharmacol Ther; 2004 Sep 15; 20(6):607-14. PubMed ID: 15352908
    [Abstract] [Full Text] [Related]

  • 10. Inflammatory mediators and acute phase proteins in patients with Crohn's disease and ulcerative colitis.
    Niederau C, Backmerhoff F, Schumacher B, Niederau C.
    Hepatogastroenterology; 1997 Sep 15; 44(13):90-107. PubMed ID: 9058126
    [Abstract] [Full Text] [Related]

  • 11. Effect of antitumour necrosis factor-alpha therapy on bone turnover in patients with active Crohn's disease: a prospective study.
    Ryan BM, Russel MG, Schurgers L, Wichers M, Sijbrandij J, Stockbrugger RW, Schoon E.
    Aliment Pharmacol Ther; 2004 Oct 15; 20(8):851-7. PubMed ID: 15479356
    [Abstract] [Full Text] [Related]

  • 12. Altered bone metabolism in inflammatory bowel disease.
    Bischoff SC, Herrmann A, Göke M, Manns MP, von zur Mühlen A, Brabant G.
    Am J Gastroenterol; 1997 Jul 15; 92(7):1157-63. PubMed ID: 9219790
    [Abstract] [Full Text] [Related]

  • 13. Serum concentrations of interleukin 6, osteocalcin, intact parathyroid hormone, and markers of bone resorption in patients with rheumatoid arthritis.
    Al-Awadhi A, Olusi S, Al-Zaid N, Prabha K.
    J Rheumatol; 1999 Jun 15; 26(6):1250-6. PubMed ID: 10381038
    [Abstract] [Full Text] [Related]

  • 14. Osteopenia in Puerto Ricans with Crohn's disease.
    Chinea B, Rosa A, Oharriz JJ, Ramírez M, Haddock L, Pérez C, Torres EA.
    P R Health Sci J; 2000 Dec 15; 19(4):329-33. PubMed ID: 11293884
    [Abstract] [Full Text] [Related]

  • 15. Abnormalities of fasting serum concentrations of peptide YY in the idiopathic inflammatory bowel diseases.
    Koch TR, Roddy DR, Go VL.
    Am J Gastroenterol; 1987 Apr 15; 82(4):321-6. PubMed ID: 3565336
    [Abstract] [Full Text] [Related]

  • 16. Antibodies against laminaribioside and chitobioside are novel serologic markers in Crohn's disease.
    Dotan I, Fishman S, Dgani Y, Schwartz M, Karban A, Lerner A, Weishauss O, Spector L, Shtevi A, Altstock RT, Dotan N, Halpern Z.
    Gastroenterology; 2006 Aug 15; 131(2):366-78. PubMed ID: 16890590
    [Abstract] [Full Text] [Related]

  • 17. Serum lysozyme in inflammatory bowel disease.
    Nugent FW, Mallari R, George H, Ridley N.
    Gastroenterology; 1976 Jun 15; 70(6):1014-6. PubMed ID: 1269861
    [Abstract] [Full Text] [Related]

  • 18. Altered levels of biochemical indices of bone turnover and bone-related vitamins in patients with Crohn's disease and ulcerative colitis.
    Gilman J, Shanahan F, Cashman KD.
    Aliment Pharmacol Ther; 2006 Apr 01; 23(7):1007-16. PubMed ID: 16573803
    [Abstract] [Full Text] [Related]

  • 19. Plasma levels of endothelin-1 in patients with Crohn's disease and ulcerative colitis.
    Letizia C, Boirivant M, De Toma G, Cerci S, Subioli S, Scuro L, Ferrari P, Pallone F.
    Ital J Gastroenterol Hepatol; 1998 Jun 01; 30(3):266-9. PubMed ID: 9759593
    [Abstract] [Full Text] [Related]

  • 20. Laboratory markers predict bone loss in Crohn's disease: relationship to blood mononuclear cell function and nutritional status.
    Trebble TM, Wootton SA, Stroud MA, Mullee MA, Calder PC, Fine DR, Moniz C, Arden NK.
    Aliment Pharmacol Ther; 2004 May 15; 19(10):1063-71. PubMed ID: 15142195
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.